FC Private Equity Realty Management Corp. Responds to Melcor REIT “Take Under” Transaction:
September 18, 2024 17:01 ET
|
Firm Capital Private Equity Realty Trust
As Feared, Melcor Developments Ltd. is Fleecing Melcor REIT Unitholders! Melcor Developments Ltd. Needs to be Honourable and Take Melcor REIT Private at NAV and Stop the Self Dealing That...
InspireSemi Announces Final Closing of Private Placement
September 18, 2024 17:01 ET
|
Inspire Semiconductor Holdings Inc.
InspireSemi Announces Final Closing of Private Placement
iLearningEngines and GenLab Venture Studio Announce Strategic Alliance to fast-track Enterprise AI Applications Using Generative AI within Global Enterprises
September 18, 2024 17:00 ET
|
iLearningEngines Holdings, Inc.
BETHESDA, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (Nasdaq: AILE) (“iLearningEngines,” “ILE,” or “the Company”), a leader in AI-powered learning and work automation for...
Fanhua Reports First Half 2024 Unaudited Financial Results
September 18, 2024 17:00 ET
|
Fanhua Inc.
GUANGZHOU, China, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanhua”), a leading independent financial services provider in China, today announced its unaudited...
Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024
September 18, 2024 17:00 ET
|
Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient...
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024 17:00 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
ROSEN, A LEADING LAW FIRM, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA
September 18, 2024 16:53 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and...
ROSEN, A LEADING LAW FIRM, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CXM
September 18, 2024 16:49 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June...
PAINWeek 2024 Unites Nearly 2,000 Clinicians to Revolutionize Pain Management
September 18, 2024 16:45 ET
|
PAINWeek
Las Vegas, Nevada, Sept. 18, 2024 (GLOBE NEWSWIRE) -- PAINWeek 2024, the largest pain management conference in the United States, concluded its four-day run from September 3-6 at the iconic...
- September 18, 2024 16:35 ET Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against New Fortress Energy Inc.
- September 18, 2024 15:54 ET Scoular’s new Kansas oilseed crush facility opens producers to growing renewable fuels market